Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's drugs
Pharma
Eisai, Biogen's subQ Leqembi delayed amid FDA's data request
What analysts viewed as a potential “inflection point” for Eisai and Biogen’s slow-footed Leqembi is facing a delay with the FDA.
Angus Liu
Apr 1, 2024 10:45am
Top 10 most anticipated drug launches of 2024
Jan 29, 2024 6:00am
Eisai, Biogen trot out data on injectable Leqembi
Oct 26, 2023 11:59am
ICER dials up recommended price for Eisai's Leqembi
Mar 1, 2023 3:25pm
CMS declines to reconsider Eisai's Leqembi for coverage
Feb 23, 2023 11:00am
Top 10 most anticipated drug launches of 2023
Feb 6, 2023 3:00am